KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$10.05M	-
CFO	Gall Matthew	235.0K	$1.06M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 17, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	1,653	$2.50	$4,125.06	-1.3%	-32.0%	-69.9%
Jul 20, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	684	$3.45	$2,362.84	-0.3%	-51.4%	-77.5%
Jul 20, 2023	Sinha Vikas84	See Remarks	Sell	2,635	$3.44	$9,076.89	-0.1%	-51.4%	-77.5%
Jul 19, 2023	Brainard Diana85	Chief Executive Officer	Sell	8,342	$3.56	$29,710.03	-0.9%	-50.3%	-77.6%
Jul 5, 2023	Brainard Diana85	Chief Executive Officer	Sell	5,275	$3.05	$16,062.90	-0.6%	-35.7%	-78.1%
Jul 5, 2023	Sinha Vikas84	See Remarks	Sell	2,983	$3.05	$9,083.53	-0.3%	-35.7%	-78.1%
Jun 9, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	5,045	$5.64	$28,452.79	-3.7%	-46.0%	-85.8%
May 18, 2023	Brainard Diana85	Chief Executive Officer	Sell	4,536	$4.21	$19,114.70	-0.5%	-36.3%	-81.1%
Apr 20, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	697	$3.67	$2,555.93	-0.3%	-10.1%	-80.2%
Apr 20, 2023	Sinha Vikas84	See Remarks	Sell	2,683	$3.66	$9,828.47	-0.1%	-10.1%	-80.2%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC